News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Racially segregated schooling tied to worse late-life cognition
By Marilynn Larkin NEW YORK (Reuters Health) - Late-life cognitive capabilities, particularly executive function and semantic memory, are likely worse among Black individuals who experienced racially
Biden signs order imposing new international travel vaccine rules, lifting restrictions
By David Shepardson (Reuters) U.S. President Joe Biden on Monday signed an order imposing new vaccine requirements for most foreign national air travelers and lifting severe travel restrictions on
Surgery needed in nearly half of appendicitis patients treated with antibiotics
By Reuters Staff (Reuters Health) - Antibiotic therapy can prevent or delay the need for an appendectomy, but ultimately nearly half of the patients will eventually require the surgery, according to
Belimumab after rituximab a promising therapeutic strategy for lupus
By Megan Brooks NEW YORK (Reuters Health) – Treatment with belimumab after rituximab reduced serum IgG anti-dsDNA antibody levels and risk for severe flares in patients with systemic lupus
Delta variant does not appear to make children sicker
By Reuters Staff (Reuters) - The Delta variant of the coronavirus does not appear to cause more severe disease in children than earlier forms of the virus, a UK study suggests. Earlier this year, the
Vaccines weaker than expected in multiple myeloma patients
By Reuters Staff (Reuters) - A new study sheds light on the vulnerability of multiple myeloma patients to the coronavirus. The study, released online on in Cancer Cell, reveals these patients not only
Cannabis vaping among adolescents soaring
By Linda Carroll (Reuters Health) - The lifetime prevalence of cannabis vaping among teens and preteens in the U.S. and Canada doubled between 2013 and 2020, while "past 12-month" use nearly doubled
COVID-19 vaccines not linked with pregnancy loss
By Reuters Staff (Reuters) - Two studies in major medical journals add to evidence that COVID-19 vaccines are safe before and during pregnancy. One study, published in The New England Journal of
Medicaid pregnancy coverage often excludes postpartum depression
By Ronnie Cohen (Reuters Health) - Low-income mothers lose health insurance coverage just weeks after delivery in many parts of the U.S., leaving them nowhere to turn while struggling with common
U.S. to invest $70 mln to boost access to COVID-19 tests
By Reuters Staff (Reuters) - The Biden administration said it will invest $70 million to boost the availability and lower costs of rapid, over-the-counter COVID-19 tests in the United States, as it
Press Release: Bausch, Clearside receive U.S. approval for eye injection
By Reuters Staff (Reuters) - Bausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their eye injection, giving patients
U.S. to outline Nov. 8 international travel reopening, vaccination rules
By David Shepardson The Biden administration plans to unveil on Monday its detailed rules requiring nearly all foreign air visitors to be vaccinated against COVID-19 starting Nov. 8, sources told
Eating nuts linked to lower risk of recurrence and death among breast-cancer survivors
By Linda Carroll NEW YORK (Reuters Health) - Breast-cancer survivors who consume a high amount of nuts may have a lower risk of recurrence and death, a new study suggests. An analysis of more than
Moderna says its COVID-19 vaccine protective, safe in young children
By Reuters Staff (Reuters) - Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, and the company plans
Cases of deadly pancreatic cancer on the rise in the US
By Reuters Staff NEW YORK (Reuters Health) - A new study finds that cases of pancreatic cancer increased among both men and women between 2000 and 2018, particularly among women 15 to 34 years of age,
Change in neuropsychiatric status in teens may signal para- or post-COVID inflammatory syndrome
By Megan Brooks NEW YORK (Reuters Health) - Researchers have detected anti-SARS-CoV-2 and autoreactive antibodies in cerebrospinal fluid (CSF) of three teenagers with COVID-19 and notable subacute
Cognitive problems seen in middle-aged COVID-19 survivors
By Reuters Staff (Reuters) - A "substantial proportion" of middle-aged COVID-19 survivors with no previous dementia had cognitive problems more than half a year after diagnosis, researchers have found
Certain CDH1 variants tied to gastric cancer risk in hereditary lobular breast cancer
By Marilynn Larkin NEW YORK (Reuters Health) - Hereditary lobular breast cancer (HLBC) patients carrying CDH1 pathogenic or likely pathogenic (P/LP) variants are apt to be at increased risk of gastric
Brain white matter connectivity disrupted in symptomless, early-onset Alzheimer's
By Marilynn Larkin NEW YORK (Reuters Health) - White matter structural connectivity was lower in symptomless autosomal-dominant Alzheimer's disease (AD) mutation carriers compared with noncarriers in
COVID-19 pandemic associated with menstrual cycle changes
By Lisa Rapaport (Reuters Health) - Many women have experienced changes in the timing, duration, and symptoms of their menstrual cycles during the COVID-19 pandemic, a recent study suggests.
'Diligent' dermatology care needed in organ-transplant recipients
By Reuters Staff NEW YORK (Reuters Health) - Organ transplant recipients (OTRs) face an increased risk for developing multiple skin cancers, "highlighting the importance of diligent dermatology
EXPLAINER-Americans wonder: Which COVID-19 booster is best?
By Julie Steenhuysen CHICAGO (Reuters) - Americans this week were handed a big decision when it comes to getting a COVID-19 vaccine booster. The U.S. Centers for Disease Control and Prevention (CDC)
Walgreens U.S. stores roll out Moderna, J&J COVID-19 booster shots
By Reuters Staff (Reuters) - Walgreens Boots Alliance Inc said on Friday its U.S. stores started administering COVID-19 booster shots from Moderna Inc and Johnson & Johnson, in addition to previously
U.S. Supreme Court to hear challenge to Texas abortion ban
By Andrew Chung (Reuters) - The U.S. Supreme Court on Friday agreed to hear a challenge by President Joe Biden's administration and abortion providers to a restrictive Texas law that imposes a
Press Release: ANALYSIS-Vaccinated Singapore shows zero-COVID countries cost of reopening
By Aradhana Aravindan SINGAPORE (Reuters) - Few are left to inoculate in wealthy Singapore after a vigorous campaign achieved a level of coverage envied by many nations battling the coronavirus
CDC director: U.S. may update definition of full vaccination for COVID-19
By Reuters Staff WASHINGTON (Reuters) - Biden administration officials urged eligible Americans on Friday to get booster shots of a COVID-19 vaccine and the Centers for Disease Control and Prevention
Heart scans can help guide chronic total occlusion PCI
By Matthew Phelan NEW YORK (Reuters Health) - Pre-procedural coronary computed-tomography angiography (CTA) boosts percutaneous coronary intervention (PCI) success rates in patients with chronic total
Many patients with proliferative diabetic retinopathy treated with ranibizumab skip follow-ups
By Linda Carroll NEW YORK (Reuters Health) - More than half of the patients in a clinical trial evaluating ranibizumab for the treatment of proliferative diabetic retinopathy (PDR) skipped follow-up
Androgen-annihilation therapy prolongs progression-free survival in metastatic prostate cancer
By Reuters Staff NEW YORK (Reuters Health) - Among men with metastatic castration-resistant prostate cancer (mCRPC), androgen-annihilation therapy significantly improved radiographic progression-free
Mental illness any time in life linked with disrupted sleep
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Inpatient diagnosis of any of a wide range of psychiatric illnesses at any time in life may be linked with disrupted sleep, a large study of
UPDATE 2-WHO issues plan to prevent sexual abuse after Congo scandal
(Adds quotes from WHO spokesperson, paras 5-6; Western diplomat, para 8) By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization issued its plan (https://bit.ly/3pq3MWI) on Thursday to
Norway opts not to give 12-15 year-olds second vaccine doses yet
By Reuters Staff OSLO (Reuters) - Norway will hold off giving children aged 12-15 a second dose of a vaccine against COVID-19 until it has gathered more research, partly due to a rare side effect
Britain says investigating Delta sublineage as possibly more transmissible
By Reuters Staff LONDON (Reuters) - The UK Health Security Agency on Friday said it designated a Delta coronavirus sublineage called AY.4.2 as a "Variant Under Investigation", saying there was some
Pfizer/BioNTech COVID-19 vaccine shows 90.7% efficacy in trial in children
By Michael Erman NEW YORK (Reuters) - The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on
Americans can mix and match COVID-19 boosters but original vaccine recommended -Fauci
By Reuters Staff WASHINGTON (Reuters) - Americans can choose a COVID-19 booster shot that is different from their original inoculation but the recommendation is to stick with the vaccine they got
U.S. CDC signs off on Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots
By Manas Mishra and Julie Steenhuysen (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Thursday recommended the COVID-19 vaccine boosters for recipients of the Moderna Inc and
Urinary peptidomic profile predicts age-related chronic diseases, excessive fibrosis
By Marilynn Larkin NEW YORK (Reuters Health) - Researchers have produced and validated a urinary peptidomic profile (UPP) biomarker that distinguishes healthy from unhealthy aging based on fibrosis
Novel antibody delivery technology boosts immunotherapy against glioblastoma in mice
By Marilynn Larkin NEW YORK (Reuters Health) - A delivery technology based on glucosylated polymers conjugated onto antibodies enhanced the accumulation and safety of checkpoint blockade therapy in a
Dapagliflozin curbs albuminuria in CKD with or without diabetes
By Marilynn Larkin NEW YORK (Reuters Health) - In patients with chronic kidney disease (CKD), with or without type 2 diabetes, the SGLT2 inhibitor dapagliflozin reduced albuminuria, according to data
UPDATE 1-WHO issues plan to prevent sexual abuse after Congo scandal
(Adds background) By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization issued its plan (https://bit.ly/3pq3MWI) on Thursday to prevent any further misconduct by aid workers deployed
REFILE-UV light from nail salon dryers may provoke lupus lesions
(Corrects formatting issue affecting some clients, no change to text) By Lisa Rapaport (Reuters Health) - Nail salon drying lamps that emit ultraviolet light may contribute to periungual cutaneous
UV light from nail salon dryers may provoke lupus lesions
By Lisa Rapaport (Reuters Health) - Nail salon drying lamps that emit ultraviolet light may contribute to periungual cutaneous lupus erythematosus lesions, according to case reports detailed in a
REFILE-WHO issues plan to prevent sexual abuse after Congo scandal
(Corrects formatting issue in first paragraph affecting some subscribers, no change to article) By Reuters Staff GENEVA (Reuters) - The World Health Organization issued its plan (
WHO issues plan to prevent sexual abuse after Congo scandal
GENEVA, Oct 21 (Reuters) - The World Health Organization issued its plan (https://bit.ly/3pq3MWI) on Thursday to prevent any further misconduct by aid workers deployed in its field operations after
Long-term spaceflight may be risky to brain health
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Cosmonauts who've returned from long-term space flight show changes in their blood biomarkers that indicate brain injury, a small pilot study
UPDATE 1-Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study
(Adds comments) By Reuters Staff BERLIN (Reuters) - A booster dose of the COVID-19 vaccine developed by Pfizer Inc and German partner BioNTech SE restored efficacy to 95.6% against disease caused by
U.S. appeals court rules against nursing homes over COVID-19 lawsuits
By Tom Hals (Reuters) - In a setback to nursing-home operators facing hundreds of COVID-19 negligence and wrongful-death lawsuits, a federal appeals court on Wednesday said cases against two New
UPDATE 1-U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots
(Adds comment from infectious disease expert) By Reuters Staff (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday are considering several
Texas targets Roe v. Wade, urges U.S. Supreme Court to maintain abortion ban
By Andrew Chung (Reuters) - Texas on Thursday asked the U.S. Supreme Court to keep in place a law that imposes a near-total ban on abortion and urged the justices that if they quickly take up a legal
U.S. CDC advisers weigh Moderna, J&J COVID-19 vaccine boosters, mix-and-match shots
By Reuters Staff (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Thursday are considering several recommendations for rollout of COVID-19 vaccine
EU regulator verdict on Moderna COVID-19 booster shot next week
By Reuters Staff LONDON (Reuters) - The European Union's drug regulator expects to announce the results of its review of Moderna's COVID-19 booster vaccine next week and also to start a rolling review
Sweden extends pause of Moderna vaccine for younger age group
By Reuters Staff STOCKHOLM (Reuters) - Sweden has extended the pause of Moderna's COVID-19 vaccine for people aged 30 and younger due to rare heart-related side effects, the public health agency said
Regret and defiance in Europe's vaccine-shy east as COVID-19 rages
By Janis Laizans and Tsvetelia Tsolova RIGA/SOFIA (Reuters) - As Latvia goes into lockdown and hospitals in Bulgaria and Romania buckle under a COVID-19 surge while Poland sells surplus vaccine doses,
EXCLUSIVE-EU decision on Russia's Sputnik V shot 'impossible' this year - source
By Emilio Parodi and Polina Nikolskaya (Reuters) - The EU drug regulator is unlikely to decide whether to approve Russia's Sputnik V coronavirus vaccine until at least the first quarter of 2022
UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine
By Reuters staff (Reuters) - The UK drug regulator added Guillain-Barré syndrome (GBS) as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on
No decline in health-related quality of life after radical cystectomy
By Reuters Staff NEW YORK (Reuters Health) - Radical cystectomy (RC) with urinary diversion does not appear to lead to a decline in health-related quality of life (HRQOL), according to a new study. RC
BP targets may not be 'one-size-fits-all'
By Megan Brooks NEW YORK (Reuters Health) - Ideal blood pressure targets may depend in part on the cardiovascular event for which an individual patient is most at risk, according to a new analysis of
British docs far more likely to be offered jobs if they are white
By Linda Carroll NEW YORK (Reuters Health) - White doctors in London are six times more likely to be offered jobs than their Black counterparts, a new report suggests. Data described in an article
After mergers, rural hospitals more likely to stop surgical services
By Brandon May NEW YORK (Reuters Health) - Rural hospitals that are acquired by larger hospitals or health systems are more likely to close their surgical services, and possibly their maternal- and
Paradoxical bronchospasm may go unrecognized in patients with COPD or asthma
By Megan Brooks NEW YORK (Reuters Health) - Paradoxical bronchospasm can represent a distinct and unrecognized phenotype of patients with obstructive lung diseases, a new study suggests. "Paradoxical
Russia reports cases of more contagious COVID-19 Delta subvariant
By Reuters Staff MOSCOW (Reuters) - Russia has reported "isolated cases" of COVID-19 with a sublineage of the Delta variant that is believed to be even more contagious, the state consumer watchdog's
Pfizer vaccine very effective against Delta variant in adolescents in Israel - study
By Reuters Staff JERUSALEM (Reuters) - The Pfizer/BioNTech COVID-19 vaccine is highly effective at preventing infection and symptomatic disease from the Delta variant among 12- to 18-year-olds,
Pfizer, BioNTech report high efficacy of COVID-19 booster shot in study
By Reuters Staff BERLIN (Reuters) - Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine
CORRECTED-Breast-cancer-prediction tool for U.S. Black women eases risk stratification
(Clarifies author's name in para 3 of story originally posted on October 19. (Corrects Dr. Palmer's name and title.)) By Marilynn Larkin NEW YORK (Reuters Health) - A risk prediction tool for breast
MRI features distinguish different types of pediatric myelitis
By Marilynn Larkin NEW YORK (Reuters Health) - Magnetic resonance imaging (MRI) can help identify a rare antibody-mediated inflammatory demyelinating disorder of the central nervous system,
REFILE-Long-term survival in NSCLC similar with stereotactic ablative radiotherapy or surgery
(Refiling to fix formatting errors experienced by some clients.) By Lisa Rapaport NEW YORK (Reuters Health) - Long-term survival after stereotactic ablative radiotherapy is noninferior to surgery for
Plants may be useful in vaccine antigen production
By Reuters Staff (Reuters) - Plants could someday be used to produce COVID-19 vaccine antigens, according to researchers who are developing a nasal spray vaccine. Vaccines work by delivering antigens,
Long-term survival in NSCLC similar with stereotactic ablative radiotherapy or surgery
By Lisa Rapaport (Reuters Health) - Long-term survival after stereotactic ablative radiotherapy is noninferior to surgery for operable stage 1 non-small-cell lung cancer, a U.S. study suggests.
Drug improves liver health in patients with NASH
By Gene Emery (Reuters Health) - A phase 2b test of 247 people with active nonalcoholic steatohepatitis (NASH) has concluded that high-dose therapy with Inventiva Pharma's lanifibranor can lower
Experimental oral COVID-19 vaccine shows promise in monkeys
By Reuters Staff (Reuters) - A COVID-19 booster vaccine that can be given by mouth to people who already have antibodies from vaccination or prior infection has yielded promising results in monkeys
Children with mild COVID-19 may lack antibodies afterward
By Reuters Staff (Reuters) - Children who contract a mild case of COVID-19 may not develop antibodies to the virus afterward, a study from Australia suggests. Researchers compared 57 children and 51
Acquired mutations linked to fat metabolism, insulin sensitivity in chronic liver disease
By Marilynn Larkin NEW YORK (Reuters Health) - For the first time, acquired (somatic) mutations that impact metabolism and insulin sensitivity were identified in liver cells of patients with chronic
Restricting travel over vaccine type could be discrimination, PAHO warns
By Daina Beth Solomon MEXICO CITY (Reuters) - Countries should grant entry to vaccinated travelers regardless of which shot they received to prevent discrimination and facilitate business, a top
UPDATE 1-U.S. surgeons successfully test pig kidney transplant in human patient
(Adds comment from PETA in new final paragraph) By Nancy Lapid NEW YORK (Reuters) - For the first time, a pig kidney has been transplanted into a human without triggering immediate rejection by the
Novavax tumbles after report on COVID-19 vaccine production delay
By Reuters Staff (Reuters) - Shares of Novavax Inc fell 16% after a report from Politico said the company faces significant hurdles in proving it can manufacture its experimental COVID-19 vaccine that
Some young people who undergo HCT retain ability to conceive
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Young people who undergo hematopoietic-stem-cell transplantation (HCT) may be able to conceive even after being treated with highly gonadotoxic
Insulin resistance tied to higher risk of major depressive disorder
By Rob Goodier NEW YORK (Reuters Health) - Three proxies for insulin resistance each may predict incident major depressive disorder, according to new research. Combined with findings from other
INSIGHT-AI can see through you: CEOs' language under machine microscope
By Tommy Wilkes LONDON (Reuters) - Executives, beware! You could become your own worst enemy. CEOs and other managers are increasingly under the microscope as some investors use artificial
UPDATE 1-U.S. readies plan to vaccinate kids ages 5-11 against COVID-19
(Adds quotes from briefing, U.S. COVID-19 statistics) By Susan Heavey WASHINGTON (Reuters) - The Biden administration on Wednesday outlined its plan to vaccinate millions of U.S. children ages 5 to 11
'Broken heart' syndrome rising in women even before pandemic
By Reuters Staff NEW YORK (Reuters Health) - Takotsubo cardiomyopathy - a rare heart-brain disorder also known as broken heart syndrome - is becoming more common among middle-aged and older women and
U.S. surgeons successfully test pig kidney transplant in human patient
By Nancy Lapid NEW YORK (Reuters) - For the first time, a pig kidney has been transplanted into a human without triggering immediate rejection by the recipient's immune system, a potentially major
Artificial intelligence can rapidly diagnose rare genetic diseases
By Megan Brooks NEW YORK (Reuters Health) - An artificial intelligence (AI)-based algorithm can quickly diagnose rare genetic diseases in critically ill children with high accuracy, allowing earlier
Can CBD oil help shrink lung tumors?
By Megan Brooks NEW YORK (Reuters Health) - An elderly woman with non-small-cell lung cancer who declined conventional treatments including surgery, chemotherapy and radiation experienced significant
Canada to require COVID-19 vaccinations for federal lawmakers
By Reuters Staff OTTAWA (Reuters) - Canada's House of Commons will require all lawmakers to be fully vaccinated against COVID-19 when they return to work next month, potentially locking out some
White House lays out plan to vaccinate kids ages 5 to 11
By Susan Heavey WASHINGTON (Reuters) - The Biden administration on Wednesday outlined its plan to vaccinate millions of kids ages 5 to 11 as soon as the COVID-19 shot is approved for younger children,
U.S. Supreme Court justice rejects challenge to Maine COVID-19 vaccine mandate
By Lawrence Hurley WASHINGTON (Reuters) - U.S. Supreme Court Justice Stephen Breyer on Tuesday turned away a religious challenge to a requirement that healthcare workers in Maine be vaccinated against
Brazil senators drop call for COVID-19 homicide charge against Bolsonaro
By Lisandra Paraguassu BRASILIA (Reuters) - Brazilian senators investigating the handling of the country's COVID-19 outbreak have dropped a recommendation from their draft report that President Jair
Gates Foundation to spend $120 mln to speed access to generics of Merck COVID-19 pill
By Julie Steenhuysen and Michael Erman (Reuters) - The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start development of generic versions of Merck & Co's
Only very old and sick die of COVID if vaccinated, Italian study shows
By Reuters Staff MILAN (Reuters) - People vaccinated against COVID-19 are highly unlikely to die of the disease unless very old and already badly ill before getting it, a study in Italy showed on
China's COVID-19 outbreak grows as cities race to trace infections
By Reuters Staff BEIJING (Reuters) - China reported a fourth day of new locally transmitted COVID-19 cases in a handful of cities across China, prompting alarmed local governments to double down on
Putin approves week-long Russian workplace shutdown as COVID-19 surges
By Alexander Marrow and Darya Korsunskaya MOSCOW (Reuters) - Russian President Vladimir Putin on Wednesday approved a government proposal for a week-long workplace shutdown at the start of November to
UK hospitals on the edge as government resists fresh COVID measures
By Alistair Smout LONDON (Reuters) - British hospitals are on the edge and people should wear masks and come forward for vaccines to stop them being overwhelmed by a rising wave of COVID-19 cases,
Pandemic impacts postpartum mother-infant bonding in multiple ways
By Marilynn Larkin NEW YORK (Reuters Health) - Pandemic-related grief, particularly depression, increased risks to maternal-infant bonding among postpartum women, whereas anxiety and health worries
Limited evidence supports many hematopoietic stem cell transplant guidelines
By Lisa Rapaport (Reuters Health) - Guidelines for hematopoietic stem cell transplants often are not supported by randomized clinical trials published in peer-reviewed journals, a new study finds.
Breast-cancer-prediction tool for U.S. Black women eases risk stratification
By Marilynn Larkin NEW YORK (Reuters Health) - A risk prediction tool for breast cancer in US Black women showed similar accuracy to current questionnaire-based models in a validation study, and seems
Omecamtiv mecarbil likely improves outcomes in severe heart failure
By Marilynn Larkin NEW YORK (Reuters Health) - In recently hospitalized patients with severe heart failure (HF), omecamtiv mecarbil (OM) reduced the composite endpoint of time to first HF event or
UPDATE 1-FDA proposes rule to make many hearing aids cheaper
(Adds Psaki comment, quotes from officials) By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Tuesday proposed creation of a new category of over-the-counter (OTC) hearing aids to
